Radiopharm Theranostics Investor Relations Material
Latest events
KOL Event
Radiopharm Theranostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Radiopharm Theranostics Limited
Access all reports
Radiopharm Theranostics Limited is a biotechnology company focused on the development of radiopharmaceutical products for the diagnosis and treatment of cancer. The company specializes in theranostics, combining therapeutic and diagnostic capabilities into a single platform. Its pipeline includes targeted radiopharmaceuticals designed to deliver precision treatments while enabling imaging for monitoring disease progression. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
RAD
Country
🇦🇺 Australia